Ardent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the Annual Meeting of Stockholders held by Ardent Health, Inc. on May 20, 2026. The filing was submitted on May 26, 2026. The company is incorporated in Delaware and its common stock trades on the New York Stock Exchange under the symbol ARDT.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
As of the record date, 143,095,662 shares were outstanding. A total of 98,778,826 shares were represented at the meeting. The following matters were voted upon:
- Director Elections: All 11 nominees were elected to the Board of Directors. While all received majority support, Rahul Sen received the lowest "For" vote count (79,335,440) and the highest "Withhold" count (12,243,316) among the nominees.
- Executive Compensation: Stockholders approved the non-binding advisory vote on executive compensation with 91,093,535 votes "For" and 300,746 votes "Against."
- Auditor Ratification: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with 97,852,830 votes "For" and 918,233 votes "Against."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.
Key Facts for Investor Verification
- Verify the specific reasons for the higher "Withhold" votes for director nominee Rahul Sen compared to other board members.
- Confirm the total number of shares outstanding (143,095,662) and the participation rate (approximately 69%) at the Annual Meeting.
- Review the Definitive Proxy Statement (Schedule 14A) filed on April 8, 2026, for detailed executive compensation data referenced in the advisory vote.
- Note that the independent auditor, Ernst & Young LLP, has been ratified for the fiscal year ending December 31, 2026.